Wells Fargo’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.3M Sell
913,693
-202,053
-18% -$3.39M ﹤0.01% 1454
2025
Q1
$17.1M Buy
1,115,746
+69,707
+7% +$1.07M ﹤0.01% 1302
2024
Q4
$23.1M Buy
1,046,039
+145,145
+16% +$3.2M 0.01% 1124
2024
Q3
$16.2M Sell
900,894
-75,066
-8% -$1.35M ﹤0.01% 1317
2024
Q2
$15.9M Buy
975,960
+50,741
+5% +$825K ﹤0.01% 1287
2024
Q1
$13.1M Buy
925,219
+633,659
+217% +$8.94M ﹤0.01% 1400
2023
Q4
$3.04M Sell
291,560
-20,872
-7% -$218K ﹤0.01% 2325
2023
Q3
$3.19M Buy
312,432
+12,113
+4% +$124K ﹤0.01% 2276
2023
Q2
$2.26M Sell
300,319
-169,034
-36% -$1.27M ﹤0.01% 2659
2023
Q1
$4.15M Sell
469,353
-134,623
-22% -$1.19M ﹤0.01% 2143
2022
Q4
$5.51M Buy
603,976
+245,749
+69% +$2.24M ﹤0.01% 1907
2022
Q3
$2.89M Sell
358,227
-36,456
-9% -$294K ﹤0.01% 2292
2022
Q2
$2.97M Buy
394,683
+87,428
+28% +$657K ﹤0.01% 2359
2022
Q1
$2.89M Sell
307,255
-37,135
-11% -$349K ﹤0.01% 2788
2021
Q4
$2.76M Buy
344,390
+15,083
+5% +$121K ﹤0.01% 2990
2021
Q3
$3.21M Sell
329,307
-257,635
-44% -$2.51M ﹤0.01% 3100
2021
Q2
$5.81M Buy
586,942
+149,407
+34% +$1.48M ﹤0.01% 2625
2021
Q1
$5.05M Buy
437,535
+54,956
+14% +$634K ﹤0.01% 2708
2020
Q4
$3.69M Sell
382,579
-95,284
-20% -$920K ﹤0.01% 2978
2020
Q3
$4.31M Sell
477,863
-66,458
-12% -$599K ﹤0.01% 2620
2020
Q2
$6.71M Sell
544,321
-579,264
-52% -$7.14M ﹤0.01% 2165
2020
Q1
$10.1M Buy
1,123,585
+379,576
+51% +$3.41M ﹤0.01% 1639
2019
Q4
$7.29M Sell
744,009
-54,616
-7% -$535K ﹤0.01% 2230
2019
Q3
$5.49M Buy
798,625
+174,339
+28% +$1.2M ﹤0.01% 2447
2019
Q2
$5.76M Sell
624,286
-81,876
-12% -$756K ﹤0.01% 2431
2019
Q1
$11.1M Buy
706,162
+9,151
+1% +$143K ﹤0.01% 1843
2018
Q4
$10.7M Sell
697,011
-368,180
-35% -$5.68M ﹤0.01% 1796
2018
Q3
$22.9M Buy
1,065,191
+330,397
+45% +$7.12M 0.01% 1417
2018
Q2
$17.9M Buy
734,794
+6,392
+0.9% +$155K 0.01% 1586
2018
Q1
$12.4M Sell
728,402
-101,159
-12% -$1.73M ﹤0.01% 1819
2017
Q4
$15.7M Sell
829,561
-771,239
-48% -$14.6M ﹤0.01% 1642
2017
Q3
$28.2M Sell
1,600,800
-253,189
-14% -$4.46M 0.01% 1211
2017
Q2
$61.6M Sell
1,853,989
-55,331
-3% -$1.84M 0.02% 756
2017
Q1
$61.3M Buy
1,909,320
+210,188
+12% +$6.74M 0.02% 754
2016
Q4
$61.6M Sell
1,699,132
-349,996
-17% -$12.7M 0.02% 716
2016
Q3
$94.3M Sell
2,049,128
-421,812
-17% -$19.4M 0.03% 529
2016
Q2
$124M Buy
2,470,940
+290,687
+13% +$14.6M 0.05% 411
2016
Q1
$117M Buy
2,180,253
+217,964
+11% +$11.7M 0.05% 414
2015
Q4
$129M Sell
1,962,289
-99,606
-5% -$6.54M 0.05% 390
2015
Q3
$116M Sell
2,061,895
-529,824
-20% -$29.9M 0.05% 412
2015
Q2
$153M Sell
2,591,719
-342,013
-12% -$20.2M 0.06% 361
2015
Q1
$183M Buy
2,933,732
+367,227
+14% +$22.9M 0.07% 313
2014
Q4
$148M Buy
2,566,505
+252,536
+11% +$14.5M 0.06% 355
2014
Q3
$124M Buy
2,313,969
+71,928
+3% +$3.87M 0.05% 394
2014
Q2
$118M Buy
2,242,041
+29,206
+1% +$1.53M 0.05% 425
2014
Q1
$117M Buy
2,212,835
+49,066
+2% +$2.59M 0.05% 417
2013
Q4
$86.7M Sell
2,163,769
-432,607
-17% -$17.3M 0.04% 495
2013
Q3
$98.1M Sell
2,596,376
-1,248,647
-32% -$47.2M 0.05% 419
2013
Q2
$151M Buy
+3,845,023
New +$151M 0.08% 302